Natera

Natera Raises $200M in Series E

Natera has successfully raised $200M in a Series E at a $2.75B valuation led by Perceptive Advisors, Goldman Sachs.

Company Overview

Natera is a Biotech company headquartered in San Carlos, CA, founded in 2003 with 2000+ employees.

Cell-free DNA testing for cancer and pregnancy

Fundraising Details

• Amount Raised: $200M
• Round Type: Series E
• Valuation: $2.75B
• Date: 2019-07-31
• Investors: Perceptive Advisors, Goldman Sachs

About Natera

Cell-free DNA testing for cancer and pregnancy The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: San Carlos, CA
• Founded: 2003
• Team Size: 2000+
• Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Natera's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Natera's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $2.75B valuation marks an important milestone for Natera, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Natera is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2019-07-31. For more information about Natera, visit their headquarters at San Carlos, CA.